Every dosage format decision in supplement formulation carries tradeoffs, and there is rarely a single correct answer that applies across every product category. Softgels, tablets, and sachets each serve genuine purposes, and understanding how formulators actually think through this decision reveals more nuance than most consumers ever consider.

Softgels, as covered extensively elsewhere, excel with fat-soluble ingredients and nutrients that benefit from being pre-dissolved in an oil base. Their main limitation is that they are not well-suited for large dosage requirements, since the shell can only accommodate so much fill volume before the capsule becomes impractically large to swallow. They also tend to carry higher manufacturing costs due to the specialized equipment and longer production cycles involved, which affects the final price point of the finished product.

Tablets remain the most versatile and cost-effective format for a wide range of ingredients, particularly those that are water-soluble or do not require an oil-based carrier for absorption. They can accommodate higher dosages more easily than softgels and are generally more stable during storage and transport due to their solid, compressed structure. Their main drawback is that certain fat-soluble ingredients simply do not achieve the same bioavailability in tablet form, and some ingredients with strong or unpleasant flavors require additional coating steps to make them palatable, adding cost and complexity to the manufacturing process.

Sachets have grown considerably in popularity over recent years, particularly for powder-based formulations meant to be dissolved in water or mixed into food. They offer flexibility for higher dosage ingredients that would require multiple tablets or capsules to deliver an equivalent amount, and they are often perceived as more convenient for consumers who prefer not to swallow pills. Their limitation lies in formulation complexity around taste masking, since powders dissolved in water expose flavor much more directly than an encapsulated format, requiring significant investment in flavoring technology to create a palatable end product.

A facility working as a genuine softgel contract manufacturer needs to guide brands honestly through these tradeoffs rather than defaulting to whichever format is easiest or most profitable for the manufacturer to produce. This means asking specific questions about the target ingredient’s solubility, the intended dosage per serving, target consumer preferences, and even practical considerations like whether the target market skews toward consumers who struggle with swallowing pills, which would favor sachets or gummies over tablets or softgels.

Cost considerations also factor heavily into this decision, and formulators need to balance the ideal delivery format against what is commercially viable for the brand’s target price point. A perfectly optimized softgel formulation is not a useful recommendation if the resulting cost per unit makes the final retail price uncompetitive in the target market. This is where experienced facilities, particularly those recognized among custom cdmo companies in indore, add genuine value, by helping brands find a format that balances scientific appropriateness with commercial viability rather than optimizing purely for one at the expense of the other.

Ultimately, the right format decision comes down to a combination of ingredient science, target consumer behavior, and commercial realities, and a good formulator weighs all three rather than defaulting to habit or convenience. Brands that engage seriously with this decision early in the development process tend to end up with products that perform better and sell better, since the format itself becomes an asset rather than an afterthought.